Site US1132 — Durham, North Carolina

Site US1132 is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Site US1132 has participated in 1 clinical trials.

Therapeutic areas: Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Prostate Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US1132?

Site US1132 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US1132 conducted?

Site US1132 has 1 clinical trials on record. Their work covers Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Prostate Cancer.

Is Site US1132 accredited by Crixeo Health?

Site US1132 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US1132?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.